Sentences with phrase «cell research collaboration»

This group will continue to be a leading force in stem cell research collaboration and networking beyond the life of the current project.

Not exact matches

Researchers from Osaka University, in collaboration with the Max Planck Institute for Polymer Research, recently found a way to produce polymer solar cells without the need for these specialized treatments, while improving its conductivity, by using amorphous polymer blends and adding a component.
This includes a stem cell research centre, a network of drug discovery institutes and a # 20 million global clinical development fund dedicated to supporting Phase I and II clinical trials; and a # 2 million collaboration between University of Cambridge and University College London that will use donated cells from people with Alzheimer's to test potential new treatments
By exploiting new molecular and genetic insights, the research, done in collaboration with Pierre de Wit from Wageningen Agricultural University in the Netherlands, provides a better understanding of the defense system of crop plants against the damaging pathogens that grow in the spaces between plant cells.
My research has implemented MFC methods for cell manipulation and molecular biology and has been applying them in collaboration with local life science researchers.
Research for the study was conducted by first co-authors Dr. Ranit Kedmi and Nuphar Veiga and colleagues at Prof. Peer's TAU Laboratory, in collaboration with Prof. Itai Benhar of TAU's School of Molecular Cell Biology and Biotechnology, Dr. Michael Harlev of TAU's Veterinary Service Center, Dr. Mark Belkhe of Integrated DNA Technologies (IDT) and Prof. Judy Lieberman of Boston Chidren's Hospital and Harvard Medical School.
This collaboration reflects work of The Center for Engineering Mechanobiology, a National Science Foundation - funded Science and Technology Center that supports interdisciplinary research on the way cells exert and are influenced by the physical forces in their environment.
In collaboration with Prof. Dr. Roland Schüle and his team at the Center of Clinical Research of the Freiburg University Medical Center, the scientists were able to test several epigenetic inhibitors that had been newly developed by Schüle and his team on the cancer stem cell model.
Harvard «has such a rich stem cell group of people, and many of them work on complementary aspects of stem cell research, so you can easily engage in collaborations and learn more about your own field and somebody else's field,» Hochedlinger says.
New research by a team of investigators at the Medical University of South Carolina (MUSC) directed by Xue - Zhong Yu, M.D., professor of Microbiology and Immunology, in collaboration with researchers at the University of Minnesota, demonstrates that one particular family of microRNAs (miRs), called miR -17-92, is responsible for the T - cell and B - cell pathogenicity that causes GVHD.
The research was conducted in the lab of Dr. Ravid Straussman of the Weizmann Institute of Science's Molecular Cell Biology Department, led by his graduate student Leore Geller and conducted in collaboration with Dr. Todd Golub and Dr. Michal Barzily - Rokini of the Broad Institute of the Massachusetts Institute of Technology.
This research was developed in collaboration with researchers from the Department of Molecular, Cell and Developmental Biology (University of California, Santa Cruz, USA) and Department of Biochemistry (University of Oxford, UK).
The research was led by TAU postgraduate student Dr. Elena Milanesi under the guidance of Dr. David Gurwitz of the Department of Human Molecular Genetics and Biochemistry of TAU's Sackler Faculty of Medicine and Sagol School of Neuroscience and Dr. Noam Shomron of the Department of Cell and Developmental Biology at TAU's Sackler Faculty of Medicine, in collaboration with Sackler graduate student Adva Hadar and Prof. Haim Werner of TAU's Sackler Faculty of Medicine, along with researchers in Italy and Germany.
Professor Dan Davis and his team at the Manchester Collaborative Centre for Inflammation Research, working in collaboration with global healthcare company GSK, investigated how different types of immune cells communicate with each other — and how they kill cancerous or infected cells.
Austrian scientists, in collaboration with researches in Australia and Germany, have now shown that a molecule called Cbl - b acts as a molecular brake for Natural Killer (NK) cells to reject cancer.
A study developed by researchers of the Institute for Plant Molecular and Cell Biology (IBMCP), a joint center of the Universitat Politècnica de València and the Spanish National Research Council (CSIC), in collaboration with the Unit for Plant Genomics Research of Evry, France (URGV, in French) has discovered a new way of improving the longevity of plant seeds using genetic engineering.
The research was carried out in collaboration with scientists from the Novosibirsk State University, and the findings were reported in the online edition of the journal Cell on 22 June 2017.
«We demonstrated that in the absence of Numb, photoreceptors are unable to send a molecule essential for vision to the correct compartment, which causes the cells to progressively degenerate and ultimately die,» adds Dr. Ramamurthy, who carried out the project in Dr. Cayouette's laboratory in collaboration with Christine Jolicoeur, research assistant.
«This collaboration enabled us to learn more about what really controls plant cell shape in one year than we had in the previous 10,» said Daniel Szymanski, Purdue professor of botany and plant pathology and leader of the research team.
A team working at the Institute of Cancer Research and the Royal Marsden Hospital in London, in collaboration with scientists at the National Cancer Institute in Bethesda, Maryland, has found that tamoxifen also works by encouraging the cells surrounding a tumour to produce a «growth factor».
Researchers at the University of Copenhagen, in collaboration with Seattle Biomedical Research Institute, the University of Oxford, NIMR Tanzania and Retrogenix LTD, have identified how malaria parasites growing inside red blood cells stick to the sides of blood vessels in severe cases of malaria.
«The Hutchison / MRC Research Centre was founded on a spirit of collaboration at many levels,» explained Ron Laskey, co-director of the centre and director of the MRC Cancer Cell Unit.
Researchers from Guillermo Montoya's team at the Spanish National Cancer Research Centre (CNIO), in collaboration with Isabelle Vernos» Group from the Centre for Genomic Regulation (CRG), have uncovered the molecular interaction between TACC3 and chTOG, key proteins in forming the internal cellular framework that enables and sustains cell division.
Scientists from the Cancer Research UK Manchester Institute, based at The University of Manchester and part of the Manchester Cancer Research Centre, teamed up with experts at AstraZeneca, as part of a collaboration agreed in 2010, to test a drug — known as AZD3965 — on small cell lung cancer cells.
Professor Masanobu Izaki and colleagues at Toyohashi University of Technology, in collaboration with researchers at the Research Center for Photovoltaic Technologies, National Institute of Advanced Industrial Science and Technology, have analyzed the structure of a zinc - based buffer layer in a CIGS solar cell at SPring8 (the world's largest third - generation synchrotron radiation facility, located in Hyogo Prefecture, Japan).
Volunteers helped her team identify cancerous cells by looking at slides from drug trials in the online collaboration Cell Slider, results of which were presented in November at the National Cancer Research Institute's annual conference.
The work was performed in collaboration with Arjan Narbad's lab at the Institute of Food Research in Norwich, UK, who tested how engineering mutations in the endolysins affected their ability to tear down the bacterial cell wall.
Today, a team led by dos Santos, in collaboration with Professor Gregory Hannon of Cancer Research UK, Cambridge Institute, and Assistant Professor William Pomerantz at the University of Minnesota, identify a protein that they show must be present in order for mammary stem cells to perform their normal functions.
Notably, the CRG team, which counted with the expertise in Mycoplasma from the Serrano's laboratory and the collaboration of the ICREA research professor Marc Marti - Renom at CNAG - CRG, discovered that Mycoplasma's circular chromosome is consistently organised the same way in all the cells, with a region called the Origin (where DNA copying begins) at one end of the structure and the midpoint of the chromosome located at the opposite end.
In collaboration with Dr. Kristin Stanford, assistant professor of physiology and cell biology at Ohio State University Wexner Medical Center, the research team carried out brown fat transplantation experiments in mice.
The first observation of correlation between isotropic growth and puzzle - like cell shape came from the Roeder Lab (Cornell University) and was then explored in collaboration with the Smith Lab (Max Planck Institute for Plant Breeding Research).
Taube Philanthropies, one of the Bay Area's foremost charitable organizations, has granted $ 750,000 to the Buck Institute for Research on Aging to support work performed by Dr. Lisa Ellerby in collaboration with the Taube Neurodegenerative Disease Stem Cell Initiative — a research consortium that is working on Huntington's Research on Aging to support work performed by Dr. Lisa Ellerby in collaboration with the Taube Neurodegenerative Disease Stem Cell Initiative — a research consortium that is working on Huntington's research consortium that is working on Huntington's disease.
In collaboration with colleague Aaron Dinner, the research team also formulated a mathematical model that depicts the regulatory network governing progenitor cell development.
Research published recently in Cell highlights the fruit of these collaborations.
«We have identified the genes and growth factors involved and, thanks to a collaboration with Microsoft Research, we can now computationally model the control circuitry in mouse cells.
Students from 13 countries attended the Summer School, made possible by the collaboration of three EU - funded stem cell research projects — EuroSyStem, OptiStem and NeuroStemCell.
April 2012 - New research: Illuminating embryonic stem cells Collaboration between two EU funded projects «Heroic» and «EuroSyStem», has provided new insights into embryonic stem cells The teams used next generation sequencing technology to examine two key properties of the cells that influence their identity and behaviour: gene expression and gene regulation.
Discover the history, evolution, and «real science» of stem cell research in a documentary made in close collaboration between filmmakers and scientists.
In close collaboration with oncologists at the Olivia Newton John Cancer Research Institute (ONJCRI), the technology was tested on blood samples from melanoma patients and was able to track critical changes in spreading tumor cells before, during and after treatment.
October 2010 - Third Call for European Stem Cell Group Final open call for EuroSyStem research network The European Stem Cell Group was founded in 2009 to bring together basic stem cell researchers from across Europe and encourage cross-disciplinary collaboratCell Group Final open call for EuroSyStem research network The European Stem Cell Group was founded in 2009 to bring together basic stem cell researchers from across Europe and encourage cross-disciplinary collaboratCell Group was founded in 2009 to bring together basic stem cell researchers from across Europe and encourage cross-disciplinary collaboratcell researchers from across Europe and encourage cross-disciplinary collaboration.
McCaskie is Director of the Arthritis Research UK Tissue Engineering Centre, a national multicentre collaboration focused on both cell and cell - free approaches to regenerative therapies in osteoarthritis.
A collaboration between Cell Press, UCSF, and MIT, this conference brings together leading thinkers in technology, biology, and data science for an innovative two and a half day meeting dedicated to the burgeoning research areas where these three fields are intersecting.
Our current efforts in the AST - VAC2 program are focused on progressing this product towards a Phase 1 / 2a clinical trial in non-small cell lung cancer in collaboration with Cancer Research UK (CRUK).
She is registred to the National Order of Biologists in the province of Palermo; collaboration in research project from 2012 to 2015 at the Department of Biopathology and Biotechnology, University of Palermo, focusing the study on the identification of molecules capable to modulate intracellular metabolic pathways for the prevention and treatment of infectious, tumor and degenerative disease, in collaboration with Prof. Angela Santoni, University of Rome; collaboration in research project in 2011 at the hospital «Villa Sofia Cervello» of Palermo to study methods can cure the genetic defect that causes thalassemia through genetic engineering; she studies different mechanisms of the differentiation and the activation of human gammadelta T cells as effector cells of the immune response against cancer and infectious diseases; she investigates about the identification and development of biomarkers of resistance and susceptibility to Mycobacterium tuberculosis infection; Valentina Orlando has published 13 papers in peer reviewed journals and 3 comunications at national and international congress.
In an effort to further exploit the potential of Pexa - Vec to activate the immune system to fight cancer, as seen in McDonald's preclinical data, SillaJen recently announced a new clinical trial in collaboration with New York - based Regeneron Inc. to test Pexa - Vec and REGN2810, a PD - 1 checkpoint inhibitor, in combination against renal cell carcinoma, and recently signed a sponsored research agreement with UCSF to enable joint support of parallel preclinical experiments by McDonald's team.
Cancer Institute research highlights include innovative studies to develop individualized approaches for treatment and prevention of lung cancer; collaboration between medical and materials science researchers to develop treatments for various types of leukemia using nanotechnology to target only cancer cells; and development of novel therapeutics to treat metastatic melanoma using an approach that regulates the processes leading to tumor development.
In collaboration with the U.S. Naval Research Laboratory, Stice hopes to use his recently developed neural cell kits to detect chemical threats.
Now, researchers at Osaka University, in an international collaboration with Max Planck Institute for Polymer Research, have redesigned one of their previously reported polymers to make a new kind of solar cell that needs no extra special treatments.
A technique already developed by Dr. Simeone's research team, in collaboration with Dr. Sunitha Nagrath, for isolating circulating tumor cells was the foundation for this novel approach to personalized therapeutics.
Enriched by the rapid evolution of these technologies, TEFOR - TACGene has developed a solid expertise in the design, production and use of TALE - N and CRISPR / Cas9 systems, both for its own research projects in cultured cells and in collaboration, in many model organisms, including the rat, zebrafish, Drosophila, and Xenopus as part of the National Infrastructure in Biology and Health TEFOR supported by Investissement d'Avenir programme (2012 - 2019).
a b c d e f g h i j k l m n o p q r s t u v w x y z